• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Biomarkers| Big Data| News, Analysis, Insights - HIT Consultant

DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression

by Jasmine Pennic 01/05/2021 Leave a Comment

DaVita & RenalytixAI Partner for Early Risk Identification to Help Slow Kidney Disease Progression

What You Should Know: - RenalytixAI and DaVita announce a program partnership that aims to slow kidney disease progression and improve outcomes for the nation’s estimated 37 million adults with chronic kidney disease (CKD). - This is the first clinical-grade program that delivers advanced early-stage prognosis and risk stratification, combined with actionable care management to the primary care level where the majority of kidney disease patients are being seen. - The program will use
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

by Fred Pennic 12/30/2020 Leave a Comment

30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021. Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

by Fred Pennic 10/30/2020 Leave a Comment

Mayo Clinic Launches Vocal Biomarker Study for Pulmonary Hypertension Detection

What You Should Know: - Mayo Clinic announced a collaboration with Vocalis Health to to research and develop new voice-based tools for screening, detecting and monitoring patient health, beginning with a study to identify vocal biomarkers to detect pulmonary hypertension (PH). - The clinical validation study will utilize Vocalis Health’s proprietary software, which can operate on any connected voice platform (mobile, computer, tablet, etc.) to analyze patients’ health based on voice
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

by Fred Pennic 10/27/2020 Leave a Comment

Medidata Acquires Digital Biomarker Business of MC10 / Clinical Trials & Wearable Sensors

What You Should Know: - Clinical trials technology company Medidata has acquired the digital biomarker business of MC10. - MC10’s offerings will bring novel clinical analytics and biosensor capabilities to Medidata’s existing technology solutions, enhancing Medidata’s capabilities to integrate data from wearable sensors – including clinical grade metrics – in clinical trials. - With this acquisition, Medidata’s integrated offering will help provide life sciences companies and device
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

by Fred Pennic 10/06/2020 Leave a Comment

AWS, PHDA Collaborate to Develop Breast Cancer Screening and Depression Machine Learning Models

What You Should Know: - Amazon Web Services (AWS) and the Pittsburgh Health Data Alliance (PHDA) announce a collaboration to produce more accurate machine learning models for breast cancer screening and depression. - In work funded through the PHDA-AWS collaboration, a research team led by Shandong Wu, an associate professor at the University of Pittsburgh Department of Radiology, is using deep-learning systems to analyze mammograms in order to predict the short‐term risk of developing
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Dept. of Defense and Philips Partner on AI Tech to Contain COVID-19

by Fred Pennic 09/22/2020 Leave a Comment

Dept. of Defense and Philips Partner on AI Tech to Contain COVID-19

Dept. of Defense and Philips Partner on AI Tech to Contain COVID-19 What You Should Know: - Today, Philips, in partnership with the U.S. Department of Defense, announced plans to expand their research on an AI-based early warning system for infectious disease, opening new possibilities in the battle to contain COVID-19. - An application of their joint Rapid Analysis of Threat Exposure (RATE) project, the technology aims to provide early alerts of potential
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch

by Jasmine Pennic 09/17/2020 Leave a Comment

Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch

What You Should Know: - Anthem, Inc. announced a new study that examines how the use of everyday devices, like Apple Watch and iPhone, may help individuals with asthma, led by the University of California, Irvine. - Launching in the fall, the two-year, randomized controlled study will enroll participants from Anthem-affiliated health plans who have been clinically diagnosed with asthma. -Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Sonde Health Acquires NeuroLex Lab’s Voice-Based Survey Platform

by Fred Pennic 08/25/2020 Leave a Comment

Sonde Health Acquires NeuroLex’s Voice-Based Survey Platform

What You Should Know: - Sonde Health acquires NeuroLex Laboratories, Inc. to forms one of the world’s preeminent biobanks focused on vocal biomarkers. - NeuroLex’s core product, SurveyLex, makes it easy to create and distribute voice surveys in less than a minute as URL links through web browsers. Sonde Health, a Boston-based digital vocal biomarker technology platform announced it has acquired NeuroLex Laboratories, Inc., a leading voice-enabled survey and data acquisition
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

CurieAI Launches AI-Driven Platform for COVID-19 Respiratory Monitoring and Management

by Jasmine Pennic 08/18/2020 Leave a Comment

CurieAI Launches AI-Driven Platform for COVID-19 Respiratory Monitoring and Management

What You Should Know: - SRI Ventures spin-off CurieAI announces the launch of its AI-driven COVID-19 case management platform - The Curie solution has been deployed to monitor inpatients and outpatients at San Carlos Apache Healthcare Corporation (SCAHC). CurieAI, a Menlo Park, CA-based healthcare startup spun-off from SRI Ventures, the corporate venture arm of SRI International, today announced the release of CurieAI’s first-of-its-kind AI-driven platform specifically designed
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform

by Jasmine Pennic 08/13/2020 Leave a Comment

Mission Bio Lands $70M to Expand Cancer Therapies With Single-Cell Multi-Omics Platform

What You Should Know: - Mission Bio raises $70 million in Series C funding led by Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics. - Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.  Mission Bio, Inc., a South San Francisco,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • 3
  • …
  • 6
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • Philips Acquires Medical Device Integration Platform Capsule for $635M Philips Acquires Medical Device Integration Platform Capsule for $635M
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 20 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • DPHO, UnitedHealthcare Launch Accountable Care Program UnitedHealth Rolls Out Employer Virtual Primary Care Plan
  • 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic 3 Steps to Maintain Telehealth’s Momentum Post-Pandemic
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |